Metropolitan Life Insurance Company (MetLife)’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,279	Closed	-$22.5K	–	666
2024 Q1	$22.5K	Hold	1,279	–	–	﹤0.01%	1800
2023 Q4	$17.7K	Hold	1,279	–	–	﹤0.01%	1970
2023 Q3	$17.5K	Hold	1,279	–	–	﹤0.01%	1960
2023 Q2	$26.1K	Buy	+1,279	New	+$26.1K	﹤0.01%	1787